Calidi Biotherapeutics Inc.
CLDI | AMEX
$1.12
+$0.01 (+0.69%)
Sep 22, 2026, 1:34 PM ET · Market open
TTM Period Ending | Q2 2026 Jun 29, 2026 | Q1 2026 Mar 30, 2026 | Q4 2025 Dec 30, 2025 | Q3 2025 Sep 29, 2025 | Q2 2025 Jun 29, 2025 | Q1 2025 Mar 30, 2025 | Q4 2024 Dec 30, 2024 | Q3 2024 Sep 29, 2024 | Q2 2024 Jun 29, 2024 | Q1 2024 Mar 30, 2024 | Q4 2023 Dec 30, 2023 | Q3 2023 Sep 29, 2023 | Q2 2023 Jun 29, 2023 | Q1 2023 Mar 30, 2023 | Q4 2022 Dec 30, 2022 | Q3 2022 Sep 29, 2022 | Q2 2022 Jun 29, 2022 | Q1 2022 Mar 30, 2022 | Q4 2021 Dec 30, 2021 | Q3 2021 Sep 29, 2021 | Q2 2021 Jun 29, 2021 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
Cash & Equivalents | 4.07M | 6.63M | 5.6M | 10.38M | 5.28M | 10.56M | 9.59M | 1.9M | 836K | 1.14M | 2.05M | 10.15M | 1.92M | 919K | 372K | 200K | 328.84K | 597.52K | 2.14M | 1.2M | 95K |
Short-Term Investments | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a |
Long-Term Investments | n/a | 119K | 119K | n/a | 102K | 123K | 129K | 129K | 356K | n/a | 230K | n/a | n/a | n/a | n/a | n/a | 230.18M | 230.02M | n/a | 230M | n/a |
Other Long-Term Assets | 784K | 777K | 800K | 989K | 867K | 21K | 892K | 88K | -129K | 506K | 143K | 1.44M | 1.64M | 868K | 725K | 151K | 77.03K | 178.99K | 66K | -1 | 507.38K |
Receivables | n/a | n/a | n/a | n/a | 50K | 50K | n/a | n/a | 181K | n/a | 1.36M | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a |
Inventory | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a |
Other Current Assets | 1.36M | 238K | 234K | 268K | 343K | 282K | 249K | 216K | 206K | 244K | 125K | 100K | n/a | n/a | 303K | 100K | n/a | n/a | 100K | n/a | n/a |
Total Current Assets | 5.43M | 7.35M | 6.26M | 11.03M | 6.05M | 11.49M | 10.23M | 2.22M | 1.63M | 1.94M | 4.3M | 11.69M | 2.81M | 1.38M | 786K | 460K | 759.67K | 1.03M | 2.74M | 2M | 117.5K |
Property-Plant & Equipment | 992K | 1.34M | 1.68M | 2.01M | 2.33M | 3.43M | 2.93M | 4.22M | 4.58M | 4.96M | 5.34M | 5.46M | 5.73M | 6.01M | 1.09M | 1.01M | n/a | n/a | 585K | n/a | n/a |
Goodwill & Intangibles | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a |
Total Long-Term Assets | 1.78M | 2.24M | 2.6M | 3M | 3.3M | 3.58M | 3.96M | 4.44M | 4.81M | 5.47M | 5.72M | 6.9M | 7.37M | 6.88M | 1.81M | 1.16M | 230.26M | 230.2M | 651K | 230M | 507.38K |
Total Assets | 7.2M | 9.59M | 8.86M | 14.03M | 9.35M | 15.06M | 14.18M | 6.66M | 6.43M | 7.41M | 10.02M | 18.59M | 10.18M | 8.26M | 2.6M | 1.62M | 231.02M | 231.24M | 3.39M | 232.01M | 624.88K |
Account Payables | 930K | 849K | 595K | 1.14M | 1.23M | 1.2M | 2.07M | 3.57M | 4.55M | 3.81M | 2.88M | 1.49M | 677K | 2.54M | 2.12M | 2.26M | n/a | n/a | 624K | n/a | n/a |
Deferred Revenue | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | 2.46M | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a |
Short-Term Debt | 1.18M | n/a | n/a | 2.28M | 775K | 1.13M | 3.18M | 3.09M | 2.98M | 4.24M | 807K | 3.35M | 9.36M | 8.13M | 5.43M | 4.05M | n/a | n/a | 5M | n/a | 188.8K |
Other Current Liabilities | 2.06M | n/a | n/a | 1.77M | 658K | 762K | 2K | 2M | -188K | 2.38M | n/a | 200K | 35.24M | 32.28M | 29.83M | 24.21M | 373.66K | 386.83K | 16.69M | 47.9K | 52.8K |
Total Current Liabilities | 3.24M | 3.84M | 3.94M | 5.19M | 5.35M | 5.43M | 9.5M | 11.58M | 13.05M | 14.95M | 10.23M | 10.87M | 53M | 49.83M | 42.99M | 35.73M | 373.66K | 386.83K | 25.96M | 47.9K | 683.18K |
Long-Term Debt | 166K | 600K | 600K | 837K | 600K | 600K | 600K | 2.37M | 1.93M | 3.38M | 2.06M | 1.95M | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a |
Other Long-Term Liabilities | 668K | 67K | 115K | 801K | 103K | 87K | 128K | 176K | 565K | 697K | 2.71M | 3.46M | n/a | n/a | 9.6M | n/a | 9.71M | 14.07M | n/a | 20.93M | n/a |
Total Long-Term Liabilities | 834K | 820K | 1.16M | 1.64M | 1.92M | 2.34M | 2.72M | 4.88M | 5.13M | 7.03M | 8.02M | 8.81M | 3.66M | 3.92M | 10.05M | 217K | 9.71M | 14.07M | 43K | 20.93M | n/a |
Total Liabilities | 4.07M | 4.66M | 5.1M | 6.83M | 7.28M | 7.77M | 12.21M | 16.46M | 18.18M | 21.98M | 18.25M | 19.68M | 56.66M | 53.75M | 53.04M | 35.94M | 10.08M | 14.45M | 26M | 20.98M | 683.18K |
Total Debt | 1.34M | 2.26M | 2.56M | 3.11M | 4.01M | 4.71M | 7.04M | 9.02M | 8.73M | 11.71M | 7.24M | 9.75M | 14.05M | 13.05M | 5.99M | 4.35M | n/a | n/a | 5.18M | n/a | 188.8K |
Book Value | 3.13M | 4.94M | 3.76M | 7.2M | 2.08M | 7.3M | 1.97M | -9.8M | -11.75M | -14.57M | -8.24M | -1.09M | -46.48M | -45.49M | -50.44M | -34.33M | 220.94M | 216.78M | -22.61M | 211.02M | -58.3K |
Book Value Per Share | 2.21 | 7.66 | 8.33 | 23.47 | 11.55 | 51.95 | 47.39 | -241.41 | -425.20 | -790.16 | -446.90 | -147.38 | -9.07K | -8.88K | -9.84K | -2.5K | 14.81K | 14.54K | -1.52K | 14.15K | -3.91 |
Common Stock | n/a | 1K | 1K | 1K | n/a | 3K | 2K | 1K | 1K | 4K | 4K | 4K | 2K | 2K | 2K | 2K | 230.18M | 230.02M | 2K | 230M | 575 |
Retained Earnings | -149.89M | -145.73M | -141.62M | -137.57M | -132.42M | -126.7M | -121.72M | -117.62M | -112.56M | -106.8M | -99.57M | -91.34M | -89.32M | -76.82M | -70.36M | -62.6M | -9.24M | -13.24M | -44.93M | -18.98M | -83.3K |
Comprehensive Income | -26K | -22K | -13K | -13K | -13K | -26K | -28K | -74K | -27K | 11K | -47K | -4K | -17K | -12K | -14K | -31K | n/a | n/a | -1K | n/a | n/a |
Shareholders Equity | 3.13M | 4.94M | 3.76M | 6.92M | 1.76M | 6.94M | 1.53M | -10.28M | -11.75M | -14.57M | -8.24M | -1.09M | -46.48M | -45.49M | -50.44M | -34.33M | 220.94M | 216.78M | -22.61M | 211.02M | -58.3K |
Total Investments | n/a | 119K | 119K | n/a | 102K | 123K | 129K | 129K | 356K | n/a | 230K | n/a | n/a | n/a | n/a | n/a | 230.18M | 230.02M | n/a | 230M | n/a |
Add to Watchlist
Select watchlists to add or remove CLDI